Guizhou Xinbang Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was CNY 1,561.306 million compared to CNY 1,511.849 million a year ago. Operating income was CNY 65.175 million compared to CNY 83.239 million a year ago. Net income was CNY 61.806 million compared to CNY 73.656 million a year ago. Basic earnings per share from continuing operations was CNY 0.04 compared to CNY 0.04 a year ago.